Shareholders Equity: The sum of preferred and common equity items.
Bright Minds Biosciences Inc. (DRUG) had Shareholders Equity of $38.82M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-2.05M |
|
-- |
|
-- |
|
$2.33M |
|
$-2.33M |
|
$0.28M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-2.33M |
|
$-2.32M |
|
7.04M |
|
7.04M |
|
$-0.29 |
|
$-0.29 |
|
| Balance Sheet Financials | |
$39.22M |
|
-- |
|
$0.11M |
|
$39.33M |
|
$0.44M |
|
$0.06M |
|
$0.06M |
|
$0.51M |
|
$38.82M |
|
$38.82M |
|
|
Shareholders Equity |
$38.82M |
7.08M |
|
| Cash Flow Statement Financials | |
$-2.73M |
|
-- |
|
$36.40M |
|
$3.98M |
|
$38.78M |
|
$34.79M |
|
$0.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
88.27 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.73M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5.29% |
|
-5.29% |
|
-5.22% |
|
-5.28% |
|
$5.48 |
|
$-0.39 |
|
$-0.39 |
|